Skip to main content

and
  1. Article

    Open Access

    De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia

    A small number of rare, recurrent genomic copy number variants (CNVs) are known to substantially increase susceptibility to schizophrenia. As a consequence of the low fecundity in people with schizophrenia and...

    G Kirov, A J Pocklington, P Holmans, D Ivanov, M Ikeda, D Ruderfer in Molecular Psychiatry (2012)

  2. No Access

    Article

    Fine map** of ZNF804A and genome-wide significant evidence for its involvement in schizophrenia and bipolar disorder

    A recent genome-wide association study (GWAS) reported evidence for association between rs1344706 within ZNF804A (encoding zinc-finger protein 804A) and schizophrenia (P=1.61 × 10−7), and stronger evidence when t...

    H J Williams, N Norton, S Dwyer, V Moskvina, I Nikolov, L Carroll in Molecular Psychiatry (2011)

  3. Article

    Erratum: Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype

    Correction to: Molecular Psychiatry (2010) 15, 146–153; published online 1 July 2008; doi:10.1038/mp.2008.66 In the abstract of the published version of this article it was stated that association signals were...

    N Craddock, L Jones, I R Jones, G Kirov, E K Green, D Grozeva in Molecular Psychiatry (2010)

  4. Article

    Open Access

    The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia

    Molecular genetic analysis offers opportunities to advance our understanding of the nosological relationship between psychiatric diagnostic categories in general, and the mood and psychotic disorders in partic...

    E K Green, D Grozeva, I Jones, L Jones, G Kirov, S Caesar in Molecular Psychiatry (2010)

  5. No Access

    Article

    Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype

    Despite compelling evidence for a major genetic contribution to risk of bipolar mood disorder, conclusive evidence implicating specific genes or pathophysiological systems has proved elusive. In part this is l...

    N Craddock, L Jones, I R Jones, G Kirov, E K Green, D Grozeva in Molecular Psychiatry (2010)

  6. No Access

    Article

    A genome-wide association study in 574 schizophrenia trios using DNA pooling

    The cost of genome-wide association (GWA) studies can be prohibitively high when large samples are genotyped. We conducted a GWA study on schizophrenia (SZ) and to reduce the cost, we used DNA pooling. We used...

    G Kirov, I Zaharieva, L Georgieva, V Moskvina, I Nikolov, S Cichon in Molecular Psychiatry (2009)

  7. No Access

    Article

    Gene-wide analyses of genome-wide association data sets: evidence for multiple common risk alleles for schizophrenia and bipolar disorder and for overlap in genetic risk

    Genome-wide association (GWAS) analyses have identified susceptibility loci for many diseases, but most risk for any complex disorder remains unattributed. There is therefore scope for complementary approaches...

    V Moskvina, N Craddock, P Holmans, I Nikolov, J S Pahwa, E Green in Molecular Psychiatry (2009)

  8. No Access

    Article

    Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

    We and others have previously reported linkage to schizophrenia on chromosome 10q25–q26 but, to date, a susceptibility gene in the region has not been identified. We examined data from 3606 single-nucleotide p...

    M C O'Donovan, N Norton, H Williams, T Peirce, V Moskvina in Molecular Psychiatry (2009)

  9. Article

    Erratum: Stage 2 of the Wellcome Trust UK–Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16–q21, 4q12–q21, 9p21, 10p14–p12 and 18q22

    Correction to: Molecular Psychiatry (2005) 10, 831–841. doi:10.1038/sj.mp.4001684 Following publication of the above article, the authors noticed that Figure 1 did not include a color key detailing the line co...

    D Lambert, F Middle, M L Hamshere, R Segurado, R Raybould, A Corvin in Molecular Psychiatry (2006)

  10. No Access

    Article

    Stage 2 of the Wellcome Trust UK–Irish bipolar affective disorder sibling-pair genome screen: evidence for linkage on chromosomes 6q16–q21, 4q12–q21, 9p21, 10p14–p12 and 18q22

    Bipolar affective disorder (BPAD) is a common psychiatric disorder with complex genetic aetiology. We have undertaken a genome-wide scan in one of the largest samples of bipolar affected sibling pairs (ASPs) u...

    D Lambert, F Middle, M L Hamshere, R Segurado, R Raybould, A Corvin in Molecular Psychiatry (2005)

  11. No Access

    Article

    Association between PRODH and schizophrenia is not confirmed

    H J Williams, N Williams, G Spurlock, N Norton, D Ivanov in Molecular Psychiatry (2003)

  12. No Access

    Article

    Mutation screening and LD map** in the VCFS deleted region of chromosome 22q11 in schizophrenia using a novel DNA pooling approach

    We examined whether variation within six genes from the VCFS critical region at 22q11 (DGSC, Stk22A1, DGSI, Gscl, Slc25A1 and Znf74) confers susceptibility to schizophrenia. We screened the exons and flanking int...

    N M Williams, G Spurlock, N Norton, H J Williams, M L Hamshere in Molecular Psychiatry (2002)